# Forecasting ESKAPE infections through a time-varying auto-adaptive algorithm using laboratory-based surveillance data

- Antonio Ballarin
^{1, 3}, - Brunella Posteraro
^{2}, - Giuseppe Demartis
^{1}, - Simona Gervasi
^{3}, - Fabrizio Panzarella
^{1}, - Riccardo Torelli
^{4}, - Francesco Paroni Sterbini
^{4}, - Grazia Morandotti
^{4}, - Patrizia Posteraro
^{5}, - Walter Ricciardi
^{2}, - Kristian A Gervasi Vidal
^{6}and - Maurizio Sanguinetti
^{4}Email author

**14**:634

https://doi.org/10.1186/s12879-014-0634-9

© Ballarin et al.; licensee BioMed Central Ltd. 2014

**Received: **17 February 2014

**Accepted: **13 November 2014

**Published: **6 December 2014

## Abstract

### Background

Mathematical or statistical tools are capable to provide a valid help to improve surveillance systems for healthcare and non-healthcare-associated bacterial infections. The aim of this work is to evaluate the **t**ime-**v**arying **a**uto-adaptive (TVA) algorithm-based use of clinical microbiology laboratory database to forecast medically important drug-resistant bacterial infections.

### Methods

Using TVA algorithm, six distinct time series were modelled, each one representing the number of episodes per single ‘ESKAPE’ (E
*nterococcus faecium*, S
*taphylococcus aureus*, K
*lebsiella pneumoniae*, A
*cinetobacter baumannii*, P
*seudomonas aeruginosa* and E
*nterobacter* species) infecting pathogen, that had occurred monthly between 2002 and 2011 calendar years at the Università Cattolica del Sacro Cuore general hospital.

### Results

Monthly moving averaged numbers of observed and forecasted ESKAPE infectious episodes were found to show a complete overlapping of their respective smoothed time series curves. Overall good forecast accuracy was observed, with percentages ranging from 82.14% for *E. faecium* infections to 90.36% for *S. aureus* infections.

### Conclusions

Our approach may regularly provide physicians with forecasted bacterial infection rates to alert them about the spread of antibiotic-resistant bacterial species, especially when clinical microbiological results of patients’ specimens are delayed.

### Keywords

ESKAPE infections Clinical microbiology laboratory data Time series analysis TVA algorithm Forecasting## Background

Despite advances in diagnostic, therapeutic and vaccination countermeasures, infectious diseases still are one of major challenges worldwide [1], which engage a lot of biomedical research and public health efforts to understand, treat, control and prevent them [2]. In particular, infections caused by antibiotic-resistant bacteria such as the ‘ESKAPE’ pathogens (E
*nterococcus faecium*, S
*taphylococcus aureus*, K
*lebsiella pneumoniae*, A
*cinetobacter baumannii*, P
*seudomonas aeruginosa* and E
*nterobacter* species), which are effectively capable of ‘escaping’ the biocidal action of antimicrobials, continue to rise and cause significant morbidity and mortality [3].

This makes the management of bacterial infections very difficult not only for hospitalized patients but also otherwise healthy non-hospitalized patients [4],[5] and, in the same time, poses the need for continuously re-evaluating global infectious disease surveillance systems [6]. To support infectious disease and/or infection control specialists locally, computerized data on the isolation of clinically relevant microbial species and their drug-resistance profiles are usually available from microbiology laboratory information systems. Thus, the patients’ outcomes may be optimized by adequate initial antibiotic therapy that would be selected on the basis of local resistance patterns [2], although it should also be important to improve the ability to predict likely infecting pathogens when empirical therapies need to be prescribed [4].

As surveillance data are often measured repeatedly at equal intervals of time, autoregressive integrated moving average (ARIMA) models, also termed Box-Jenkins models [7], which use time series analyses [8], appear to be powerful tools to monitor and predict the incidence of several infectious diseases, including dengue [9], malaria [10], haemorrhagic fever with renal syndrome [11] and hepatitis E [12], as well as the influenza-related mortality [13]. Furthermore, by using an extension of the ARIMA method called transfer function [8], a temporal relationship between antimicrobial use and resistance was demonstrated for the ceftazidime and Gram-negative bacilli and the imipenem and *P. aeruginosa* combinations [14]. Employing ARIMA or autoregressive moving average (ARMA) models for time series forecasts has become increasingly popular, but the major limitation with their use is the pre-assumed linearity of the models [15], that often leads to combining them with other statistical techniques [12].

The objective of this study was to evaluate a time series method using a **t**ime-**v**arying **a**uto-adaptive (TVA) algorithm for forecasting drug-resistant bacterial infections, through use of the data collected in a large Italian hospital microbiology laboratory. By this approach, we were able to predict the frequency on a monthly basis of single ESKAPE infectious episodes in inpatient or outpatient healthcare settings.

## Methods

### Study setting

General Hospital ‘Agostino Gemelli’ from the Università Cattolica del Sacro Cuore (Rome, Italy) is a 1500-bed tertiary care facility, which comprises a full range of medical and surgical specialties, a paediatric unit, a maternity unit, a cardiovascular surgery unit and four (general, neonatal, paediatric and post-surgical) intensive care units. It was opened in 1964 as the referral hospital for a healthcare area of approximately 200 000 inhabitants, and in 2004 it was enlarged to enclose a multifunctional platform, in which are housed centralized diagnostic laboratories, operating rooms and the Emergency Department. The entire structure admits ~50 000 patients per year.

In 1998, a multidisciplinary team, composed of a small, technically focused, clinical group of microbiologists, hygienists, epidemiologists and physicians, was formed with tasks of the infection prevention and control and, recently, the antimicrobial stewardship. Members of this group share the reports on local microbial ecology data, which are collected at the hospital level (see below) in order to adapt patient care to the infection risk.

### Microbiological data set

This study was conducted using local data that were exported daily from the clinical microbiology laboratory information system, by means of VIGIguard™ Active Surveillance Epidemiology software (bioMérieux Diagnostics Search, Marcy l’Étoile, France), and were reported into a customized database. Data included the patient identifiers, hospital wards or outpatient services, types of specimen, species of isolates and antimicrobial susceptibility patterns of the isolates. With respect to the last-named data, minimum inhibitory concentrations were determined and interpreted according to the Clinical and Laboratory Standards Institute breakpoints [16]. Duplicate or multiple isolates were disregarded, and only the first one of each species per patient was maintained into the database and used for our analysis. With regards to the specimen sources, bacterial isolates were recovered from non-invasive (lower respiratory tract or urine) and invasive (blood or cerebrospinal fluid) specimens.

### Study design, time series and forecasting algorithm

This study was ecologically designed, and utilized no patients’ identities (names and hospital codes) or personal information. Overall microbiology laboratory data were retrieved from January 2002 to July 2011, and those with respect to the six ESKAPE microorganisms were extracted and their daily numbers, summed per month, were used for one-step-ahead forecasting purposes. Thus, data utilized for the analysis included monthly time series of isolates of *E. faecium*, *S. aureus*, *K. pneumoniae*, *A. baumannii*, *P. aeruginosa* and *Enterobacter* species, all of which representing single drug-resistant infectious episodes. The first 36 months of data (January 2002 to December 2004) were used as the training set, whereas all remaining data were used to evaluate the forecasting method. We computed optimal single-series forecasts for the ESKAPE infection occurrence, using a univariate method where forecasts are dependent only on present and past values of the single series being forecasted, possibly augmented by a function of time such as a linear trend [17]. For each time series, forecast accuracy was assessed at the horizon of 30 days in advance, which, to our view, would reflect the ongoing nature of healthcare surveillance policies. Data from each time series were treated as individual time series and analysed and evaluated separately. No present and past values of other (predictor or explanatory) variables were assessed.

Before our attempt to forecast each time series, we conducted preliminary descriptive analyses of the data to identify relevant features, such as autocorrelation, seasonal patterns, trend, outliers and any other notable fluctuations, in the series. Also, we evaluated whether or not each time series was stationary (i.e., whether or not basic statistical properties such as the mean and variance of the series remained constant through time). Initial data analysis was conducted via the visualization of time plots and correlograms and the computation of basic descriptive statistics.

*f*(

*x*,

*t*) represents a certain time-dependent observation, its average value must be transformed as follows:

where *T*(*t*) represents the characteristic time parameter that, in turn, depends on the phenomenon *f*(*x*, *t*) observed in a defined time window. As *T*(*t*) can be applied to time series analysis, TVA algorithm allows to determine, for each point of the time series, a *T*(*t*) value that is able to forecast the next value [18].

where *x*
_{
t
} indicates the point of the time series considered at time *t*; *r*
_{
k
} expresses the degree of correlation between the value detected at time *t* and the value detected at *t* + *k*, that is, *x*
_{
t+k
}; *N* indicates the total number of infections in the series analysed; and $\overline{x}$ represents the average value of the series calculated on the *N*. As each point *x*
_{
t
} of the series is typically composed of three components, that is, seasonal (*S*
_{
t
}), trend (*T*
_{
t
}), and casual (*U*
_{
t
}), according to *x*
_{
t
} = *S*
_{
t
} + *T*
_{
t
} + *U*
_{
t
}, the time moving average (MA) was chosen as a filter to remove the component *U*
_{
t
}, thus maintaining unchanged the other components, in a sub-interval *Q* of *N* infections according to the equation ${\overline{x}}_{k}=\frac{1}{Q}{\displaystyle \sum _{t=k-Q}^{k}{x}_{t}}$ where *Q* is a function of the single series analysed.

The forecast of monthly infections was carried out on both the original, not filtered series {*x*
_{
k
}} and the series after application of the time filters $\left\{{\overline{x}}_{k}\right\}$. In the former case, the value’s tendency was derived by the inverse of above equation, that is, ${\widehat{x}}_{k}=Q{\overline{x}}_{k}^{*}-{\displaystyle \sum _{t=k-Q}^{k-1}{x}_{t}}$ where ${\overline{x}}_{k}^{*}$ is the forecast produced at step *k* for the average time series $\left\{{\overline{x}}_{k}\right\}$. To assess forecast accuracy, we also computed the mean absolute error (MAE) and the mean absolute percentage error (MAPE) parameters, according to the following equations:

$MAE=\frac{1}{N}{\displaystyle \sum _{k=0}^{N-1}\left|{V}_{k+1}-{F}_{k}\right|}\phantom{\rule{0.5em}{0ex}}\mathit{MAPE}=\frac{1}{N}{\displaystyle \sum _{k=0}^{N-1}100\left|\frac{{V}_{k+1}-{F}_{k}}{{V}_{k+1}}\right|}$ where *F*
_{
k
} represents the forecasting value, calculated at step *k*, of the series $\left\{{\overline{x}}_{k}\right\}$ for the value *V* recorded at step *k* +1, that is, *V*
_{
k + 1}. A lower MAPE value indicates a better fit of the time series data.

### Ethical review

The present study was reviewed by the institutional review committee of the Università Cattolica del Sacro Cuore, and it was found that utilization of clinical laboratory surveillance data did not require oversight by an ethics committee.

## Results

### Data characteristics

A total of 33 185 non-duplicate bacterial isolates, that were found to be *in vitro* resistant to one or more antimicrobials, were obtained from single infectious episodes of inpatients and outpatients between January 2002 and July 2011, as reported into the clinical microbiology laboratory database. As accounting for 92.6% of above episodes, *Escherichia coli* (29.6%), *P. aeruginosa* (15.6%), *S. aureus* (13.1%), *A. baumannii* (12.4%), *K. pneumoniae* (6.9%), *Proteus mirabilis* (4.1%), *Enterobacter* species (3.9%), *Stenotrophomonas maltophilia* (3.6%) and *E. faecium* (3.4%) were the most frequently isolated species during the study time period. Among drug-resistant ESKAPE isolates, 75.9% of *E. faecium* isolates were resistant to vancomycin, 91.7% of *S. aureus* isolates to methicillin, 95.0% of *K. pneumoniae* isolates to extended-spectrum cephalosporins, 80.8% of *A. baumannii* isolates to carbapenems, 47.3% of *P. aeruginosa* isolates to carbapenems and extended-spectrum cephalosporins, and 85.6% of *Enterobacter* species (*E. cloacae*, *E. aerogenes*, *E. agglomerans* and *E. sakazaki*) isolates to extended-spectrum cephalosporins. Therefore, starting from the original database, we chose to obtain 6 distinct ESKAPE time series, each one corresponding to the number of episodes per single infecting species that had occurred monthly during the 9-year time period.

### TVA algorithm for ESKAPE infection forecasting

*E. faecium*,

*S. aureus*,

*K. pneumoniae*,

*A. baumannii*,

*P. aeruginosa*and

*Enterobacter*species infections, by using 3-, 4-, 6- or 12-month MAs as appropriate.

Therefore, a forecasting TVA algorithm was built starting from the hypothesis that each value within a generic time series is influenced by the values occurred previously and that it, in turn, will influence future values. After a random-span time window was defined *a priori*, the time series values were clustered, and to each cluster was associated a value derived from computing the probability function. The resulting cluster values were ordered and the first ranking number was considered as the most likely value for the next trial.

*E. faecium*infections to a value of 90.36% for

*S. aureus*infections.

**Monthly forecasting of** “**ESKAPE**” **infections**: **assessment parameters and performance of the time**-**varying auto**-**adaptive algorithm**

Bacterial species | No. of recorded infections (years 2002– 2011) | Time MA (months) | MAPE | Accuracy rate (%) |
---|---|---|---|---|

| 1,142 | 3 | 9.22 | 82.14 |

| 4,332 | 4 | 5.15 | 90.36 |

| 2,284 | 12 | 3.09 | 89.61 |

| 4,106 | 12 | 3.18 | 84.93 |

| 5,165 | 3 | 4.94 | 87.95 |

| 1,293 | 6 | 7.23 | 84.34 |

## Discussion

As a widely applicable, multidisciplinary science, forecasting is an important activity for statisticians, economists, operational researchers, management scientists and decision scientists, as well as it has become an essential that drives decision-making in many fields of economic, industrial and scientific planning [17]. In the healthcare setting, forecasting has been explored as a method to improve emergency department services, where accurate forecasts of demand can guide the allocation of human and physical resources to allow an efficient patient flow [19],[20]. This, in turn, may minimize patient care delays and improve the overall quality of care. Likewise, emergence and re-emergence of infectious diseases with pandemic potential has led to growing interest in their analysis [21], so now a large amount of infectious disease data is routinely collected by laboratories, healthcare providers and government agencies in an effort to prevent, detect and manage infectious diseases outbreaks. In this context, one-step-ahead forecasts, especially when syndromic information is incorporated into the forecasting model, can be used to detect high-risk areas for outbreaks and, consequently, to develop efficient targeted surveillance [22].

While the time series analysis is used to extract meaningful statistics and other characteristics of data, time series forecasting is able to predict future values of the series based on its historical values. However, with time-series data, the modelling process is complicated by the need to model not only the interdependence between the series, but also the serial dependence within the component series [17]. Several technical resources are available to guide analysts in building and interpreting correlation models [23],[24], as well as review articles [8],[25],[26] and biomedical examples are also available [27],[28]. Thus, good forecasting depends on finding a suitable model for a given time series but, despite a plenty of software available to make it easy to fit the class of linear stochastic processes, namely ARIMA models, it is still difficult to know when to use an ARIMA model and how to choose which ARIMA model to use. ARIMA models have long been applied in various medical specialties [8],[29], until to recently predict the infectious disease incidence due to its structured modelling basis and acceptable forecasting performance [9]-[12]. However, obtaining an ARIMA model that closely fit a type of time series data requires that different ARIMA models are simultaneously constructed and checked for their goodness-of-fit prior to reach the satisfactory final model [11],[12],[14]. To this regard, it is noteworthy that an artificial neural network [17] was used in combination with an ARIMA model to take into account the linear and nonlinear behaviours of time series data, in order to forecast hepatitis E infections in Shanghai [12]. Accordingly, in a recent comparison of the models’ forecasting accuracy, the multivariate seasonal ARIMA model (SARIMA), an expanded form of ARIMA, was shown to be the most appropriate for forecasting the number of patients admitted to the emergency department per day, as it was built to incorporate explanatory variables affecting that number [20].

The present study describes the development of TVA algorithm as a simple and reliable tool to predict future trends of drug-resistant ESKAPE infections. We noticed that the noise of each time series analysed (e.g., absence of periodicity, presence of instrumental errors and non-uniformity of measures) did not influence the TVA algorithm’s forecasting capability. Also, the TVA-algorithm forecast performance on filtered time series (i.e., purged of their casual components) was higher than 80%, as documented by MAPE measurements that gave good estimates of the actual time series (Table 1). Consistent with other studies [11],[14], MAs were here used as an easy and intuitive means, even though more sophisticated techniques, such as exponential and/or adaptive MAs, Kalman filters, Holt-Winter filters [17], would have to be employed to refine the forecast results. Thus, it is surprising that such a simple algorithm is capable of producing such good predictions, but this is possible because infectious episodes are outbreaks and, therefore, are self-exciting processes which would be expected to cluster at high values. How TVA algorithm performs as we go into the future it needs to be explored. To strengthen our findings, ARMA models of order (2,3), (1,3), (1,1), (2,1), (1,2) and (1,1) (the figures indicate autoregressive and moving average terms) were constructed using the training set 36-month data to provide adequate model fit for monthly ESKAPE infections due to *E. faecium*, *S. aureus*, *K. pneumoniae*, *A. baumannii*, *P. aeruginosa* and *Enterobacter* species, respectively. However, these models allowed forecast accuracies of 61.11% (*E. faecium*), 48.65% (*S. aureus*), 67.17% (*K. pneumoniae*), 73.02% (*A. baumannii*), 63.01% (*P. aeruginosa*) and 53.42% (*Enterobacter* species) (data not shown), that were much lower than those obtained using TVA algorithm (Table 1).

As ideally forecasts are an integral part of the planning system, and not a separate exercise [17], it is desirable that a relatively simple forecasting method, which is widely understood, can allow people who will actually use the forecasts (i.e., hospital epidemiologists) to suggest control action. Thus, while a forecast of an increasing death rate for a particular disease may lead to preventive action to try to reduce the spread of the disease [30], an abnormally high methicillin-resistant *S. aureus* (MRSA) infection rate at the hospital or unit level (i.e., medical intensive care unit) may lead to an education-based intervention to increase compliance with hand-disinfection procedures [31], or to abolish individual-level MRSA decolonization programs [32]. Alternatively, the forecast can be used as a target value [17]. In this sense, it may permit to continuously monitor, and eventually correct, hospital antimicrobial stewardship programs, that have proven highly successful in improving patient outcomes, reducing adverse events (including *Clostridium difficile*), reducing re-admission rates and even reducing antibiotic resistance [33].

Therefore, our method could be practically implemented in a clinical setting to provide attending physicians with forecasted rates of drug-resistant bacterial infections on a regular basis. This in order to alert them about the spread of bacterial species displaying resistance to one or more antimicrobials, and, in the meantime, to help them in the empirical prescription of antimicrobials when the microbiology (culture and/or susceptibility testing) results of clinical specimens are not yet available.

Our findings may have important clinical repercussions. The challenge of antimicrobial resistance continue to grow locally and globally, and this necessitates a significant shift in mind-set about the infection control, which is now considered to be vital to aid prevent the spread of resistant microorganisms [34]. To this regard, surveillance and feedback of results to clinicians is crucial to performance improvement in managing both healthcare- and non-healthcare-associated drug-resistant infections [35]. Therefore, surveillance data should possibly be accurate and consistent to effectively monitor trends and outbreaks, particularly for infections caused by MRSA, vancomycin-resistant enterococci and multidrug-resistant Gram-negative bacteria, including *Acinetobacter* and *Pseudomonas* species [36].

## Conclusion

Surveillance systems must include microbiology laboratory reporting of the isolation of clinically significant pathogens with relevant drug susceptibilities included [35], but it would also be advisable that the use of computer-based searches of laboratory records is supported from mathematical modelling and prediction, such as the TVA algorithm described here. While the success of such a method, when implemented, will greatly depend on accessible and regularly updated surveillance reports, further studies are yet needed to provide a large-scale evaluation of this potentially useful epidemiological tool.

## Declarations

### Acknowledgments

This study was supported by the UCSC (Università Cattolica del Sacro Cuore) – Linea D1 grants to BP and MS. We would like to acknowledge Emanuele Leoncini for helpful discussions on the manuscript.

## Authors’ Affiliations

## References

- Fauci AS, Morens DM: The perpetual challenge of infectious diseases. N Engl J Med. 2012, 366: 454-461. 10.1056/NEJMra1108296.View ArticlePubMedGoogle Scholar
- Nicolau DP: Current challenges in the management of the infected patient. Curr Opin Infect Dis. 2011, 24 (Suppl 1): 1-10. 10.1097/01.qco.0000393483.10270.ff.View ArticleGoogle Scholar
- Pendleton JN, Gorman SP, Gilmore BF: Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013, 11: 297-308. 10.1586/eri.13.12.View ArticlePubMedGoogle Scholar
- Carmeli Y: Strategies for managing today's infections. Clin Microbiol Infect. 2008, 14 (Suppl 3): 22-31. 10.1111/j.1469-0691.2008.01957.x.View ArticlePubMedGoogle Scholar
- Boucher HW, Talbot GH, Benjamin DK, Bradley J, Guidos RJ, Jones RN, Murray BE, Bonomo RA, Gilbert D: Infectious Diseases Society of America: 10 x '20 Progress–development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis. 2013, 56: 1685-1694. 10.1093/cid/cit152.View ArticlePubMedPubMed CentralGoogle Scholar
- Gorman S: How can we improve global infectious disease surveillance and prevent the next outbreak?. Scand J Infect Dis. 2013, 45: 944-947. 10.3109/00365548.2013.826877.View ArticlePubMedGoogle Scholar
- Box GEP, Jenkins GM: Time Series Analysis: Forecasting and Control. 1976, Holden-Day, San Francisco, CAGoogle Scholar
- Helfenstein U: Box-Jenkins modelling in medical research. Stat Methods Med Res. 1996, 5: 3-22. 10.1177/096228029600500102.View ArticlePubMedGoogle Scholar
- Luz PM, Mendes BV, Codeço CT, Struchiner CJ, Galvani AP: Time series analysis of dengue incidence in Rio de Janeiro, Brazil. Am J Trop Med Hyg. 2008, 79: 933-939.PubMedGoogle Scholar
- Gaudart J, Touré O, Dessay N, Dicko AL, Ranque S, Forest L, Demongeot J, Doumbo OK: Modelling malaria incidence with environmental dependency in a locality of Sudanese savannah area, Mali. Malar J. 2009, 8: 61-10.1186/1475-2875-8-61.View ArticlePubMedPubMed CentralGoogle Scholar
- Liu Q, Liu X, Jiang B, Yang W: Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model. BMC Infect Dis. 2011, 11: 218-10.1186/1471-2334-11-218.View ArticlePubMedPubMed CentralGoogle Scholar
- Ren H, Li J, Yuan ZA, Hu JY, Yu Y, Lu YH: The development of a combined mathematical model to forecast the incidence of hepatitis E in Shanghai, China. BMC Infect Dis. 2013, 13: 421-10.1186/1471-2334-13-421.View ArticlePubMedPubMed CentralGoogle Scholar
- Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA: Influenza and the winter increase in mortality in the United States, 1959–1999. Am J Epidemiol. 2004, 160: 492-502. 10.1093/aje/kwh227.View ArticlePubMedGoogle Scholar
- López-Lozano JM, Monnet DL, Yagüe A, Burgos A, Gonzalo N, Campillos P, Saez M: Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents. 2000, 14: 21-31. 10.1016/S0924-8579(99)00135-1.View ArticlePubMedGoogle Scholar
- Enders W: Applied Econometric Time Series. 2004, John Wiley & Sons, New York, NYGoogle Scholar
- Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21. 2011, Clinical and Laboratory Standards Institute, Wayne, PAGoogle Scholar
- Chatfield C: Time Series Forecasting. 2000, Chapman & Hall⁄CRC, Boca Raton, FLView ArticleGoogle Scholar
- Ballarin A, Gervasi S, Bacchetti S, Capponi U, Costi S, Gervasi Vidal KA, Moore PB, Nardone C, Passali G, Sagone F, Signori M, Vollera F: On the forecasting abilities of a time varying auto-adapting algorithm. Neural Parallel Sci Comput. 2010, 18: 343-356.Google Scholar
- Jones SS, Thomas A, Evans RS, Welch SJ, Haug PJ, Snow GL: Forecasting daily patient volumes in the emergency department. Acad Emerg Med. 2008, 15: 159-170. 10.1111/j.1553-2712.2007.00032.x.View ArticlePubMedGoogle Scholar
- Kam HJ, Sung JO, Park RW: Prediction of daily patient numbers for a regional emergency medical center using time series analysis. Healthc Inform Res. 2010, 16: 158-165. 10.4258/hir.2010.16.3.158.View ArticlePubMedPubMed CentralGoogle Scholar
- Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L: Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014, 14: 480-10.1186/1471-2334-14-480.View ArticlePubMedPubMed CentralGoogle Scholar
- Corberán-Vallet A, Lawson AB: Prospective analysis of infectious disease surveillance data using syndromic information. Stat Methods Med Res 2014, Mar 21 [Epub ahead of print].,Google Scholar
- Box GEP, Jenkins GM, Reinsel GC: Time Series Analysis: Forecasting and Control. 1994, Prentice Hall, Englewood Cliffs, NJGoogle Scholar
- Brockwell PJ, Davis RA: Time Series: Theory and Methods. 1991, Springer-Verlag, New YorkView ArticleGoogle Scholar
- Helfenstein U: Box-Jenkins modelling of some viral infectious diseases. Stat Med. 1986, 5: 37-47. 10.1002/sim.4780050107.View ArticlePubMedGoogle Scholar
- Zeger SL, Irizarry R, Peng RD: On time series analysis of public health and biomedical data. Annu Rev Public Health. 2006, 27: 57-79. 10.1146/annurev.publhealth.26.021304.144517.View ArticlePubMedGoogle Scholar
- Monnet DL, Lopez-Lozano JM, Campillos P, Burgos A, Yague A, Gonzalo N: Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect. 2001, 7 (Suppl 5): 29-36. 10.1046/j.1469-0691.2001.00071.x.View ArticlePubMedGoogle Scholar
- Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R: Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant
*Staphylococcus aureus*bacteremia. Clin Infect Dis. 2006, 43: 971-978. 10.1086/507636.View ArticlePubMedGoogle Scholar - Crabtree BF, Ray SC, Schmidt PM, O'Connor PJ, Schmidt DD: The individual over time: time series applications in health care research. J Clin Epidemiol. 1990, 43: 241-260. 10.1016/0895-4356(90)90005-A.View ArticlePubMedGoogle Scholar
- Matthews L, Woolhouse M: New approaches to quantifying the spread of infection. Nat Rev Microbiol. 2005, 3: 529-536. 10.1038/nrmicro1178.View ArticlePubMedGoogle Scholar
- Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV: Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000, 356: 1307-1312. 10.1016/S0140-6736(00)02814-2.View ArticlePubMedGoogle Scholar
- Sandri AM, Dalarosa MG, Ruschel De Alcantara L, Da Silva Elias L, Zavascki AP: Reduction in incidence of nosocomial methicillin-resistant
*Staphylococcus aureus*(MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol. 2006, 27: 185-187. 10.1086/500625.View ArticlePubMedGoogle Scholar - File TM, Srinivasan A, Bartlett JG: Antimicrobial stewardship: importance for patient and public health. Clin Infect Dis. 2014, 59 (Suppl 3): S93-96. 10.1093/cid/ciu543.View ArticlePubMedGoogle Scholar
- Murray E, Holmes A: Addressing healthcare-associated infections and antimicrobial resistance from an organizational perspective: progress and challenges. J Antimicrob Chemother. 2012, 67 (Suppl 1): i29-36. 10.1093/jac/dks200.View ArticlePubMedGoogle Scholar
- Wilson AP, Kiernan M: Recommendations for surveillance priorities for healthcare-associated infections and criteria for their conduct. J Antimicrob Chemother. 2012, 67 (Suppl 1): i23-28. 10.1093/jac/dks198.View ArticlePubMedGoogle Scholar
- Akova M, Daikos GL, Tzouvelekis L, Carmeli Y: Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012, 18: 439-448. 10.1111/j.1469-0691.2012.03823.x.View ArticlePubMedGoogle Scholar

## Copyright

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.